Drug intelligence / Profile preview

Gastromucin

Development stage
Unknown
Lead developer
Tianzhi Pharmaceutical
Administration
Oral
01

Overview

Gastromucin (also known as Gastromucoprotein or 胃膜素) is a biologic drug derived from porcine gastric mucosa, with mucoprotein as its primary active component. It functions as a mucosal protective agent by utilizing its strong adhesive properties to form a physical barrier on the inner wall of the digestive tract. This barrier specifically coats ulcerated areas, shielding damaged tissue from the corrosive effects of gastric acid and facilitating the healing process. Additionally, Gastromucin inhibits the enzymatic activity of pepsin, further reducing mucosal aggression. While it is long-established and approved for the treatment of gastric and duodenal ulcers, it is also being clinically investigated for its potential in managing inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, often in combination with probiotic therapies.

Brand names
Gastromucin
Other names
Gastromucoprotein胃膜素Gastric membrane extract
02

Targets

PEP (Pepsin)

Beyond the preview

Go deeper on Gastromucin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastromucin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call